ProKidney Corp. (PROK)
NASDAQ: PROK · IEX Real-Time Price · USD
2.110
-0.080 (-3.65%)
At close: Jul 19, 2024, 4:00 PM
2.140
+0.030 (1.42%)
Pre-market: Jul 22, 2024, 6:38 AM EDT
ProKidney Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ProKidney stock have an average target of 7.25, with a low estimate of 3.00 and a high estimate of 16. The average target predicts an increase of 243.60% from the current stock price of 2.11.
Analyst Consensus: Buy
* Price targets were last updated on Jun 10, 2024.
Analyst Ratings
The average analyst rating for ProKidney stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +184.36% | Jun 10, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +89.57% | May 29, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $3 | Hold | Initiates | $3 | +42.18% | Mar 7, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $8 → $2 | Strong Buy → Hold | Downgrades | $8 → $2 | -5.21% | Jan 2, 2024 |
| BTIG | BTIG | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +658.29% | Jul 25, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.99
from -0.57
EPS Next Year
-0.69
from -0.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 220.5M | 638.2M |
| Avg | n/a | n/a | n/a | 214.2M | 620.0M |
| Low | n/a | n/a | n/a | 205.8M | 595.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 197.9% |
| Avg | - | - | - | - | 189.4% |
| Low | - | - | - | - | 178.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.36 | -0.26 | -0.42 |
| Avg | -0.99 | -0.69 | -0.72 |
| Low | -2.31 | -1.01 | -1.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.